118 related articles for article (PubMed ID: 12939413)
1. Brain isoprostanes: a marker of lipid peroxidation and oxidative stress in AD.
Irizarry MC; Hyman BT
Neurology; 2003 Aug; 61(4):436-7. PubMed ID: 12939413
[No Abstract] [Full Text] [Related]
2. Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia.
Yao Y; Zhukareva V; Sung S; Clark CM; Rokach J; Lee VM; Trojanowski JQ; Praticò D
Neurology; 2003 Aug; 61(4):475-8. PubMed ID: 12939420
[TBL] [Abstract][Full Text] [Related]
3. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
Praticò D; MY Lee V; Trojanowski JQ; Rokach J; Fitzgerald GA
FASEB J; 1998 Dec; 12(15):1777-83. PubMed ID: 9837868
[TBL] [Abstract][Full Text] [Related]
4. Dietary antioxidants and dementia.
Gale CR
Int Psychogeriatr; 2001 Sep; 13(3):259-62. PubMed ID: 11768373
[No Abstract] [Full Text] [Related]
5. Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2.
Zhu M; Gu F; Shi J; Hu J; Hu Y; Zhao Z
Free Radic Biol Med; 2008 Nov; 45(10):1493-9. PubMed ID: 18822370
[TBL] [Abstract][Full Text] [Related]
6. Isoprostanes: are they more than physiopathological biomarkers of lipid peroxidation?
Cracowski JL; Baguet JP
Circulation; 2003 Jun; 107(24):e222; author reply e222. PubMed ID: 12821598
[No Abstract] [Full Text] [Related]
7. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
[TBL] [Abstract][Full Text] [Related]
8. The neurobiology of isoprostanes and Alzheimer's disease.
Praticò D
Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
[TBL] [Abstract][Full Text] [Related]
9. [Isoprostanes: new markers of oxidative stress in human diseases].
Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
[TBL] [Abstract][Full Text] [Related]
10. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases.
Greco A; Minghetti L; Levi G
Neurochem Res; 2000 Oct; 25(9-10):1357-64. PubMed ID: 11059806
[TBL] [Abstract][Full Text] [Related]
11. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease.
Nourooz-Zadeh J; Liu EH; Yhlen B; Anggård EE; Halliwell B
J Neurochem; 1999 Feb; 72(2):734-40. PubMed ID: 9930747
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, isoprostanes and hepatic fibrosis.
Comporti M; Arezzini B; Signorini C; Vecchio D; Gardi C
Histol Histopathol; 2009 Jul; 24(7):893-900. PubMed ID: 19475535
[TBL] [Abstract][Full Text] [Related]
13. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
14. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 3: Biomarkers and mediators in vascular physiology and disease].
Cracowski JL; Berdeaux O; Durand T
Pathol Biol (Paris); 2005 Jul; 53(6):364-8. PubMed ID: 16004949
[TBL] [Abstract][Full Text] [Related]
15. Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò D; Iuliano L; Mauriello A; Spagnoli L; Lawson JA; Rokach J; Maclouf J; Violi F; FitzGerald GA
J Clin Invest; 1997 Oct; 100(8):2028-34. PubMed ID: 9329967
[TBL] [Abstract][Full Text] [Related]
16. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
17. F(2) isoprostanes, potential specific markers of oxidative damage in human retina.
Nourooz-Zadeh J; Pereira P
Ophthalmic Res; 2000; 32(4):133-7. PubMed ID: 10828732
[TBL] [Abstract][Full Text] [Related]
18. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer.
Mannello F; Tonti GA; Pagliarani S; Benedetti S; Canestrari F; Zhu W; Qin W; Sauter ER
Int J Cancer; 2007 May; 120(9):1971-6. PubMed ID: 17266038
[TBL] [Abstract][Full Text] [Related]
19. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.
Swardfager W; Yu D; Scola G; Cogo-Moreira H; Chan P; Zou Y; Herrmann N; Lanctôt KL; Ramirez J; Gao F; Masellis M; Swartz RH; Sahlas DJ; Chan PC; Ojeda-Lopez C; Milan-Tomas A; Pettersen JA; Andreazza AC; Black SE
Neurobiol Aging; 2017 Nov; 59():91-97. PubMed ID: 28756941
[TBL] [Abstract][Full Text] [Related]
20. Increased CSF F2-isoprostane concentration in probable AD.
Montine TJ; Beal MF; Cudkowicz ME; O'Donnell H; Margolin RA; McFarland L; Bachrach AF; Zackert WE; Roberts LJ; Morrow JD
Neurology; 1999 Feb; 52(3):562-5. PubMed ID: 10025788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
